10/6/2011

Taiwanese researchers have discovered that people with myelodysplastic syndromes who have lower levels of the angiopoietin-1 protein were less likely to progress to acute myeloid leukemia and survived longer compared with patients who had higher levels of the protein. The protein plays a role in the formation of new blood vessels, according to the study published in the British Journal of Cancer.

Full Story:
MDSBeacon.com

Related Summaries